Lanthanum Carbonate Tablet, Chewable
Product Images NDC 67877-256

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lanthanum Carbonate (NDC 67877-256). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lanthanum-1000mg-10s-container-label (Lanthanum 1000mg 10s Container Label)

Lanthanum-1000mg-10s-container-label (Lanthanum 1000mg 10s Container Label)
Active Ingredient: 1,000 mg of lanthanum NDC 67877-258-11 as lanthanum carbonate hydrate Inactive Ingredients: Lanthanum Carbonate, Crospovidone, maltitol, and sodium stearate. Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Do not swallow tablets whole. Chew or crush tablets completely before swallowing. Take with or immediately after meals. Manufactured by Anken Laboratories Ltd., Mumbai - 400 013, INDIA. Distributed by Ascend Laboratories, LLC - Bedminster, NJ 07921. This text provides information about a medication containing lanthanum carbonate hydrate in a chewable tablet form. It includes details on the dosage, inactive ingredients, storage instructions, administration, manufacturing, and distribution information.*
FDA Label Image

Lanthanum-1000mg-carton-label (Lanthanum 1000mg Carton Label)

FDA Label Image

Lanthanum-500mg-45s-container-label (Lanthanum 500mg 45s Container Label)

Lanthanum-500mg-45s-container-label (Lanthanum 500mg 45s Container Label)
This text contains information about Lanthanum Carbonate Chewable Tablets, with the active ingredient being 500 mg of lanthanum carbonate hydrate. Inactive ingredients include Crospovidone, maltitol, and sodium stearyl fumarate. The tablets should not be swallowed whole but rather chewed or crushed completely before swallowing, and should be taken with or immediately after meals. It also provides storage instructions, prescribing information, and manufacturing and distribution details. The label also instructs pharmacists to dispense the enclosed Medication Guide to each patient. The tablets are distributed by Ascend Laboratories, LLC in Bedminster, NJ, and the manufacturer is Alkem Laboratories Ltd. in Mumbai, India. The package contains 45 tablets.*
FDA Label Image

Lanthanum-500mg-carton-label (Lanthanum 500mg Carton Label)

Lanthanum-500mg-carton-label (Lanthanum 500mg Carton Label)
This text provides information on Lanthanum Carbonate Chewable Tablets, including dosage instructions, inactive ingredients, storage guidelines, and details for patients and pharmacists. It also mentions the manufacturer and distributor of the medication. The tablets should not be swallowed whole and need to be chewed or crushed before swallowing, and they are meant to be taken with or after meals. Healthcare providers should dispense the enclosed Medication Guide to each patient. Store the tablets at the recommended temperature range.*
FDA Label Image

Lanthanum-750mg-15s-container-label (Lanthanum 750mg 15s Container Label)

Lanthanum-750mg-15s-container-label (Lanthanum 750mg 15s Container Label)
This is a description of a medication labeled as Lanthanum Carbonate Chewable Tablets. It contains 750 mg of lanthanum as lanthanum carbonate hydrate. It instructs to chew or crush tablets before swallowing, not to swallow them whole, and to take with or immediately after meals. The inactive ingredients include Crospovidone, mannitol, and sodium stearyl fumarate. It provides storage instructions, manufacturer details, and distribution information. The text recommends consulting the package insert for full prescribing information and advises pharmacists to dispense the medication guide to each patient. The manufacturer is Alkem Laboratories Ltd. in Mumbai, India, and it is distributed by Ascend Laboratories, LLC in Bedminster, NJ.*
FDA Label Image

Lanthanum-750mg-carton-label (Lanthanum 750mg Carton Label)

Lanthanum-750mg-carton-label (Lanthanum 750mg Carton Label)
This is a description of "Lanthanum Carbonate Chewable Tablets" that provides instructions for use, including not swallowing tablets whole but instead crushing or chewing them before swallowing. The tablets are recommended to be taken with or immediately after meals. The text also includes details for pharmacists, such as the recommendation to dispense the enclosed Medication Guide to each patient and information about storage conditions for the product. The tablets contain 750 mg of lanthanum carbonate hydrate and include inactive ingredients like Crospovidone and sodium stearyl fumarate. The information for patients emphasizes following the doctor's prescribing instructions. The description also mentions the manufacturer, Akem Laboratories Ltd in India, and the distributor, Ascend Laboratories, LLC in Basking Ridge, NJ.*
FDA Label Image

Lanthanum-fig1 (Lanthanum Fig1)

FDA Label Image

Lanthanum-struc (Lanthanum Struc)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.